Last Updated: 24/11/2022
Selecting clinical dose of a long acting oral formulation of ivermectin
Objectives
To enhance the ability to quantitatively inform optimal dose of a novel long acting formulation of ivermectin.
Principal Institution
Principal Investigators / Focal Persons
External reference
Thematic Categories
Date
Oct 2021 — Sep 2022
Total Project Funding
$126,126
Funding Details
Gates Foundation (GF), United States
Grant ID: INV-034321
Project Site
Deep Dives